The News Feed

Pharmaceuticals

Mild Thyroid Eye Disease May Respond to Doxycycline

More work still needs to be done, though, as the drug’s improvement rate was fairly low.
October 4, 2022

ImprimisRx Launches Compounded Antibiotic and Product Replacement Program

The company says it’ll replace the formulation—marketed as Fortisite—when expired, at no cost.
October 3, 2022

Large Study Identifies Drug Associations with Angle Closure; Added Risk in Question

Some of these were already documented, but newly identified ones included drugs for constipation and nausea.
September 27, 2022

Hypotensive Drugs Impact Clarity of Intraocular Lenses

Additional investigation is needed to further clarify this correlation and its clinical implications.
September 12, 2022

Even Small Financial Incentives Influence Prescribing Habits

Reported receipt of any non-research support from pharmaceutical manufacturers, regardless of amount, was associated with an almost doubled probability of a prostaglandin drug Rx.
August 2, 2022

Study: Two-thirds of Patients Have Skin Reactions to Topical Ophthalmic Meds

Active ingredients, especially aminoglycoside antibiotics, were the main cause.
July 19, 2022

Antibiotic Resistance Remains Prevalent in Ocular Staphylococcal Infections

Newest ARMOR study data helps inform clinicians when choosing a therapy to pursue in affected patients.
May 11, 2022

Hearing Loss a Possible Complication of Thyroid Eye Disease Drug

A small case series of teprotumumab-treated patients experienced auditory changes and other otologic symptoms.
March 8, 2022

Teprotumumab Promising as Treatment For Proptosis, Diplopia

Compared with placebo and methylprednisolone, the drug was associated with greater symptomatic improvement.
February 25, 2022

Oral CAIs More Safe Than Many Believe

The risk of adverse events was comparable to that of topical formulations, study finds.
February 1, 2022